Rampart Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Rampart Investment Management's ABBV Position: Q4 2020 in Review
Rampart Investment Management sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 10,928 shares — an estimated $957K sold.
Rampart Investment Management first reported a position in ABBV in Q1 2017 and held it in 15 quarters. The position peaked at $4.04M in Q1 2018. 2,598 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.
- Rampart Investment Management reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
- Rampart Investment Management sold 10,928 AbbVie shares in Q4 2020, an estimated $957K.
- Rampart Investment Management first reported a position in AbbVie in Q1 2017 and held it in 15 quarters.
- Rampart Investment Management's AbbVie position peaked at $4.04M in Q1 2018.
- 2,598 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.
Based on Rampart Investment Management's 13F filing for Q4 2020.